Best Immunotherapy with Keytruda (Pembolizumab) Immunotherapy with Keytruda (Pembolizumab): TOP 60 doctors

Author of 40+ peer-reviewed publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy); member of the Turkish Medical Oncology Association and the European Head & Neck Society.

Why patients choose Dr. Bülent Karagöz:

• Treatment based on U.S. protocols through Anadolu Medical Center’s strategic collaboration with a leading U.S. institution — Johns Hopkins Medicine.
• 40+ scientific publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy).
• Former department head (GATA) and professor/department chair (Okan University, Turkey) — leadership and clinical experience at major centers.
• Treats solid tumors (e.g., breast, lung, colorectal), applying modern regimens guided by tumor biology.
• Anadolu Medical Center holds ESMO designation and JCI accreditation — meaning the doctor treats according to international protocols, within a multidisciplinary team, with strict safety oversight.

She has been working as an internal medicine specialist and medical oncology specialist at Anadolu Medical Center since 2021.
 

Dr. Solak specializes in treating various cancers, including lung and gastrointestinal cancers, with extensive training at Hacettepe University Cancer Institute.

• Completed fellowship at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Specializes in breast, testicular, ovarian, and head-neck cancers
• Graduated from Hacettepe University Faculty of Medicine

Dr. Pelles Sharon specializes in immunotherapy with Keytruda at Sourasky Medical Center, bringing extensive research and clinical expertise to cancer treatment.

• Conducted significant research on patient attitudes towards clinical trials
• Offers a wide range of advanced cancer treatments
• Experienced in various surgical and non-surgical oncology procedures
• Works at one of Israel's leading medical centers

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – a pioneer in immunotherapy research for sarcoma.

• Over 41 years of experience specializing in sarcoma and immunotherapy treatments
• ESMO faculty member for sarcoma treatment protocols
• Published extensively on immunotherapy outcomes in bone cancers
• Fellowship-trained at Institut Gustave Roussy – Europe's leading sarcoma center

Principal investigator of clinical trials in cancer therapies – Dr. Sarid brings cutting-edge immunotherapy expertise to Sourasky Medical Center.

• Senior oncologist at Ichilov since 2009 with 38 years of experience in cancer treatment
• Specializes in biological cancer therapy including Keytruda applications
• Oxford-trained in cancer urology with 30+ published research articles
• Active member of ESMO and ASCO – global oncology standards

Dr. Buhl specializes in treating brain metastases and vascular anomalies, combining clinical expertise with groundbreaking research.

• Author of 47 scientific papers on neuropathology
• Founder of a fund dedicated to brain tumor research
• Performs minimally invasive and endoscopic neurosurgery
• Recognized expert in neuro-oncology and vascular pathologies

Dr. Ram Ron specializes in Immunotherapy with Keytruda (Pembrolizumab) at Sourasky Medical Center (Ichilov), offering advanced treatment options.

• Special interests include cutting-edge immunotherapy treatments
• Practices at a leading medical center known for oncology
• Focused on patient-centered care with personalized treatment plans

Dr. Ron Ram has performed several hundred stem cell transplants and published over 30 scientific articles, showcasing his deep expertise in oncology.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Fellowship-trained at New York Medical College, Westchester Medical Center
• Published a chapter in a medical textbook
• Works at Sourasky Medical Center (Ichilov)

300+ bone marrow and umbilical blood transplantations performed – Dr. El Hasid leads pediatric oncohematology at Dana Dwek Children's Hospital.

• Head of Pediatric Oncohematology and Oncology Department
• Member of American Association for Hematology
• 50+ publications and 40 conference reports
• Trained at City of Hope Hospital in Los Angeles